Index Venture Associates IV Ltd — Quarterly 13F Portfolio Report
Index Venture Associates IV Ltd
CIK: 0001447962
Long-term holder
Total reported value
—
Reporting period: 2020-09-30 · Number of holdings: 0
Index Venture Associates IV Ltd disclosed 0 holdings in its latest 13F filing for the period ending 2020-09-30, with total reported value of — and a quarterly turnover rate of 0.0%.
Sector classification currently covers about 0% of this portfolio's disclosed value; the remainder includes holdings (e.g. unmapped tickers, options, or other security types) not yet covered by our sector mapping.
Position changes disclosed by Index Venture Associates IV Ltd for the quarter ending 2020-09-30, including ticker, issuer, weight change, shares change, and action
What is Index Venture Associates IV Ltd and what type of investor is it?
Index Venture Associates IV Ltd is a investment manager that files SEC Form 13F quarterly, disclosing its U.S. public equity holdings to regulators. As of the most recent reporting period (2020-09-30), the firm manages a tracked equity portfolio valued at approximately —, spread across 0 disclosed positions.
What are Index Venture Associates IV Ltd's largest equity positions?
Based on the latest 13F filing, Index Venture Associates IV Ltd's top holdings by market value are:
1. Minerva Neurosciences INC (NERVGBP) — $0.0
What changes did Index Venture Associates IV Ltd make in its most recent portfolio filing?
No notable portfolio changes were recorded for Index Venture Associates IV Ltd in the most recent quarter. Holdings appear to have remained relatively stable.
What sectors does Index Venture Associates IV Ltd focus on?
Sector breakdown data is not yet available for Index Venture Associates IV Ltd. Check back after the next 13F processing cycle.